Top Story

Iluvien earns marketing authorization in Ireland

November 26, 2014

Alimera Sciences announced that marketing authorization has been granted to Iluvien in Ireland.

Through the repeat use application procedure, the Irish Health Products Regulatory Authority granted marketing authorization to Iluvien (fluocinolone acetonide intravitreal implant) for the treatment of vision impairment associated with chronic diabetic macular edema that is unresponsive to available therapies, according to a company press release.

BLOG: We gotta do a better job

November 26, 2014
As a Philadelphian, I am especially fond of our football team. After several years of having a contender for the playoff games, our longstanding coach seemed to have had…
Meeting News Coverage

Drug eluting contact lenses 'worthy of investigation' for release of myopia drugs

November 26, 2014
DENVER – The combination of atropine and pirenzepine with commercial hydrogel and silicone hydrogel contact lenses may warrant further investigation, according to…
In the Journals

Cost, insurance authorization affect decision making in treatment of uveitis

November 26, 2014
Among uveitis and retina specialists, cost, insurance prior authorization, pregnancy considerations and subspecialty practice were factors affecting therapeutic…
More News Headlines »

NEI grants $1 million to re-create ocular stem cells

November 25, 2014
The National Eye Institute has granted researchers at the Icahn School of Medicine at Mount Sinai a 5-year $1 million…
More »

Pre-AMD: Duty to warn?

November 3, 2014
In my last post a few weeks ago I used the term “pre-AMD.” I love this term. I have been using it since…
More »
Meeting News Coverage Video
thumbnail for video 3903645528001

VIDEO: Forced infusion phaco

November 22, 2014
NEW YORK — At OSN New York 2014, Uday Devgan, MD, discusses forced infusion phaco in cataract surgery.
More »